# Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

> **NCT03823079** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 50 (estimated)

## Conditions studied

- Recurrent Colorectal Carcinoma
- Thrombopenia

## Interventions

- **DRUG:** rhTPO
- **DRUG:** irinotecan
- **DRUG:** Raltitrexed
- **RADIATION:** radiotherapy
- **DRUG:** rhIL-11

## Key facts

- **NCT ID:** NCT03823079
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03823079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03823079, "Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03823079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*